GZMA and neoplasm: We also identified a subtype of proliferative T cells (Cluster 7 with high KI67 expression) which displayed both effector T-cell features (e.g., GZMA) and dysfunctional markers such as LAG3, TIGIT, and PD-1, indicating compromised tumor cytotoxic activity (Fig. 3d).